{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:10:01Z","timestamp":1788826201871,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.biopha.2021.112140","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T05:50:45Z","timestamp":1632721845000},"page":"112140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation"],"prefix":"10.1016","volume":"143","author":[{"given":"Mona M.","family":"Saber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz M.","family":"Al-mahallawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Stork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2021.112140_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"38","key":"10.1016\/j.biopha.2021.112140_bib2","doi-asserted-by":"crossref","first-page":"40734","DOI":"10.18632\/oncotarget.5754","article-title":"Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells","volume":"6","author":"Kumar","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.biopha.2021.112140_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2016.9","article-title":"Efficacy of cisplatin-based immunochemotherapy plus alloSCT in high-risk chronic lymphocytic leukemia: final results of a prospective multicenter phase 2 HOVON study","volume":"51","author":"van Gelder","year":"2016","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.biopha.2021.112140_bib4","article-title":"Complete remission of acute myeloid leukemia following cisplatin based concurrent therapy with radiation for squamous cell laryngeal cancer","volume":"2016","author":"Mody","year":"2016","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.biopha.2021.112140_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-8722-2-21","article-title":"Temozolomide and cisplatin in relapsed\/refractory acute leukemia","volume":"2","author":"Seiter","year":"2009","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2021.112140_bib6","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.4161\/cc.20770","article-title":"Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells","volume":"11","author":"Pan","year":"2012","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.biopha.2021.112140_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2013.04.015","article-title":"The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL\/T-LL cancer cells","volume":"336","author":"Rosilio","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2021.112140_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/cddis.2012.13","article-title":"Therapeutic metformin\/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy","volume":"3","author":"Shi","year":"2012","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2021.112140_bib9","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1158\/0008-5472.CAN-10-3471","article-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","volume":"71","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.biopha.2021.112140_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"18","key":"10.1016\/j.biopha.2021.112140_bib11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2165\/00003495-200363180-00001","article-title":"Metformin: new understandings, new uses","volume":"63","author":"Hundal","year":"2003","journal-title":"Drugs"},{"issue":"5927","key":"10.1016\/j.biopha.2021.112140_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/304664c0","article-title":"Two cubic phases in monoolein\u2013water system","volume":"304","author":"Larsson","year":"1983","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2021.112140_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1208\/s12249-009-9293-3","article-title":"Formulation of dacarbazine-loaded cubosomes-part I: influence of formulation variables","volume":"10","author":"Bei","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2021.112140_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0927-7757(96)03563-7","article-title":"A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase","volume":"114","author":"Nylander","year":"1996","journal-title":"Colloids Surf A: Physicochem. Eng. Asp."},{"issue":"6","key":"10.1016\/j.biopha.2021.112140_bib15","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1021\/la047590p","article-title":"Cubic phase nanoparticles (Cubosome): principles for controlling size, structure, and stability","volume":"21","author":"Barauskas","year":"2005","journal-title":"Langmuir: ACS J. Surf. Colloids"},{"issue":"8","key":"10.1016\/j.biopha.2021.112140_bib16","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1021\/nl050678i","article-title":"Self-assembled lipid superstructures: beyond vesicles and liposomes","volume":"5","author":"Barauskas","year":"2005","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2021.112140_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120490","article-title":"Norfloxacin loaded nano-cubosomes for enhanced management of otitis externa: In vitro and in vivo evaluation","volume":"600","author":"Al-Mahallawi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2021.112140_bib18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejpb.2013.04.018","article-title":"Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro\/in vivo characterization","volume":"86","author":"Morsi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2021.112140_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118567","article-title":"The effect of the saturation degree of phospholipid on the formation of a novel self-assembled nano-micellar complex carrier with enhanced intestinal permeability","volume":"569","author":"Ahmed","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.112140_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1208\/s12249-019-1380-5","article-title":"Enhanced permeation of methotrexate via loading into ultra-permeable niosomal vesicles: fabrication, statistical optimization, ex vivo studies, and in vivo skin deposition and tolerability","volume":"20","author":"Al-mahallawi","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.biopha.2021.112140_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","article-title":"Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam","volume":"485","author":"Al-mahallawi","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.biopha.2021.112140_bib22","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/leu.2016.192","article-title":"A review of new agents evaluated against pediatric acute lymphoblastic leukemia by the pediatric preclinical testing program","volume":"30","author":"Jones","year":"2016","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.biopha.2021.112140_bib23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.7150\/jca.19873","article-title":"Metformin sensitizes leukemia cells to vincristine via activation of AMP-activated protein kinase","volume":"8","author":"Yi","year":"2017","journal-title":"J. Cancer"},{"issue":"32","key":"10.1016\/j.biopha.2021.112140_bib24","doi-asserted-by":"crossref","first-page":"51435","DOI":"10.18632\/oncotarget.9843","article-title":"Biguanides sensitize leukemia cells to ABT-737-induced apoptosis by inhibiting mitochondrial electron transport","volume":"7","author":"Velez","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.biopha.2021.112140_bib25","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.jtho.2018.07.102","article-title":"Metformin enhances cisplatin-induced apoptosis and prevents resistance to cisplatin in co-mutated KRAS\/LKB1 NSCLC","volume":"13","author":"Moro","year":"2018","journal-title":"J. Thorac. Oncol.: Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"6","key":"10.1016\/j.biopha.2021.112140_bib26","first-page":"7557","article-title":"Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1\/2","volume":"14","author":"Dang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2021.112140_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8678634","article-title":"Metformin synergistically enhances cisplatin-induced cytotoxicity in esophageal squamous cancer cells under glucose-deprivation conditions","volume":"2016","author":"Yu","year":"2016","journal-title":"BioMed. Res. Int."},{"issue":"5","key":"10.1016\/j.biopha.2021.112140_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"Rattan","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.biopha.2021.112140_bib29","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10162-013-0431-y","article-title":"Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line","volume":"15","author":"Chang","year":"2014","journal-title":"J. Assoc. Res. Otolaryngol.: JARO"},{"issue":"1","key":"10.1016\/j.biopha.2021.112140_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejphar.2010.11.005","article-title":"Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt","volume":"651","author":"Janjetovic","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112140_bib31","first-page":"12","article-title":"Evaluation of antagonistic effects of metformin with Cisplatin in gastric cancer cells","volume":"8","author":"Lesan","year":"2014","journal-title":"Int. J. Hematol. -Oncol. Stem Cell Res."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221009240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:52:26Z","timestamp":1771919546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221009240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":31,"alternative-id":["S0753332221009240"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112140","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin dampens cisplatin cytotoxicity on leukemia cells after incorporation into cubosomal nanoformulation","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112140","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112140"}}